|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:333-339
© 2002 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease (ACD) |
From Krankenhaus München Bogenhausen, München, Germanya; Glenfield General Hospital, Leicester, United Kingdomb; CHR Cote De Nacre, Caen, Francec; Clinico Universitario, Valencia, Spaind; and Albertinen Krankenhaus, Hamburg, Germany.e
Received for publication Sept 6, 2001. Revisions requested Nov 20, 2001; revisions received Dec 14, 2001. Accepted for publication Dec 18, 2001. Address for reprints: Walter B. Eichinger, MD, Deutsches Herzzentrum München, Department of Cardiovascular Surgery, Lazarettstrasse 36, D-80636, München, Germany (E-mail: eichinger{at}dhm.mhn.de).
Objective: The purpose of this study was to prospectively evaluate the clinical and hemodynamic performance of the Mosaic bioprosthesis (Medtronic, Inc, Minneapolis, Minn).
Methods: The stented porcine bioprosthesis combines the amino-oleic acid antimineralization treatment and the zero-pressure differential fixation technique for improved tissue durability. From February 1994 to May 1999, a total of 561 patients underwent valve replacement with the Mosaic bioprosthesis at 5 centers in Europe: 461 in the aortic and 100 in the mitral position. There were 261 women and 300 men; mean age at implantation was 70 years (range, 23-89 years). Mean follow-up was 2.9 years (range, 0-6.2 years), with a total follow-up of 1710.1 patient-years.
Results: Postoperative mortality was 4.2% per patient-year, including a valve-related mortality of 0.4% per patient-year. The freedom from event rates in the aortic position at 5 years and in the mitral position at 4 years were, respectively, 96.6% ± 1.1% and 94.9% ± 3.3% for primary thromboembolism, 96.4% ± 5.0% and 87.1% ± 4.8% for antithromboembolic-related hemorrhage, 99.1% ± 0.5% and 100% for thrombosed prosthesis, 98.8% ± 1.2% and 100% for structural valve deterioration, 98.8% ± 0.7% and 100% for nonstructural dysfunction, 98.4% ± 0.6% and 94.4% ± 3.8% for endocarditis, and 95.4% ± 1.6% and 95.3% ± 3.7% for explant and reoperation. Mean pressure gradient values at 5 years ranged from 7.5 to 15.9 mm Hg in the aortic position and at 4 years from 2.0 to 6.9 mm Hg in the mitral position across all valve sizes.
Conclusions: Clinical and hemodynamic performance of the Mosaic bioprosthesis were very satisfactory during the first 6 years after clinical introduction.
This article has been cited by other articles:
![]() |
R. Guenzinger, W. B. Eichinger, I. Hettich, S. Bleiziffer, D. Ruzicka, R. Bauernschmitt, and R. Lange A prospective randomized comparison of the Medtronic Advantage Supra and St Jude Medical Regent mechanical heart valves in the aortic position: is there an additional benefit of supra-annular valve positioning? J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 462 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gudbjartsson, T. Absi, and S. Aranki Mitral Valve Replacement Card. Surg. Adult, January 1, 2008; 3(2008): 1031 - 1068. [Full Text] |
||||
![]() |
M. J. Dalmau, J. Maria Gonzalez-Santos, J. Lopez-Rodriguez, M. Bueno, A. Arribas, and F. Nieto One year hemodynamic performance of the Perimount Magna pericardial xenograft and the Medtronic Mosaic bioprosthesis in the aortic position: a prospective randomized study Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 345 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nowell, E. Wilton, H. Markus, and M. Jahangiri Antithrombotic therapy following bioprosthetic aortic valve replacement Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Magne, P. Mathieu, J. G. Dumesnil, D. Tanne, F. Dagenais, D. Doyle, and P. Pibarot Impact of Prosthesis-Patient Mismatch on Survival After Mitral Valve Replacement Circulation, March 20, 2007; 115(11): 1417 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Weber, J. Jouan, A. Matsunaga, E. Pettenazzo, T. Joudinaud, G. Thiene, and C. M.G. Duran Evidence of mitigated calcification of the Mosaic versus Hancock Standard valve xenograft in the mitral position of young sheep. J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1137 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Guenzinger, W. B. Eichinger, F. Botzenhardt, S. Bleiziffer, I. Wagner, R. Bauernschmitt, S. M. Wildhirt, and R. Lange Rest and Exercise Performance of the Medtronic Advantage Bileaflet Valve in the Aortic Position Ann. Thorac. Surg., October 1, 2005; 80(4): 1319 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Botzenhardt, W. B. Eichinger, S. Bleiziffer, R. Guenzinger, I. M. Wagner, R. Bauernschmitt, and R. Lange Hemodynamic Comparison of Bioprostheses for Complete Supra-Annular Position in Patients With Small Aortic Annulus J. Am. Coll. Cardiol., June 21, 2005; 45(12): 2054 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Eichinger, F. Botzenhardt, A. Keithahn, R. Guenzinger, S. Bleiziffer, I. Wagner, R. Bauernschmitt, and R. Lange Exercise hemodynamics of bovine versus porcine bioprostheses: A prospective randomized comparison of the mosaic and perimount aortic valves J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1056 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Daebritz, B. Fausten, B. Hermanns, J. Schroeder, J. Groetzner, R. Autschbach, B. J. Messmer, and J. S. Sachweh Introduction of a flexible polymeric heart valve prosthesis with special design for aortic position Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 946 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seitelberger, J. Bialy, R. Gottardi, G. Seebacher, R. Moidl, M. Mittelbock, P. Simon, and E. Wolner Relation between size of prosthesis and valve gradient: comparison of two aortic bioprosthesis Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 358 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Daebritz, J. S. Sachweh, B. Hermanns, B. Fausten, A. Franke, J. Groetzner, B. Klosterhalfen, and B. J. Messmer Introduction of a Flexible Polymeric Heart Valve Prosthesis With Special Design for Mitral Position Circulation, September 9, 2003; 108(90101): II-134 - 139. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |